Cargando…

Giant pulmonary artery aneurysm in a patient with vasoreactive pulmonary hypertension: a case report

BACKGROUND: Pulmonary artery aneurysms are a rare condition, frequently associated with pulmonary hypertension. However, the evolution and treatment of this pathology is still not clear. CASE PRESENTATION: The authors report a case of a 65-year old patient with pulmonary artery aneurysm associated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Araújo, Inês, Escribano, Pilar, Lopez-Gude, María Jesus, Lopez-Guarch, Carmen Jimenez, Sanchez, Maria Antonia, Ruiz-Cano, Maria J, Delgado, Juan, Cortina, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228743/ https://www.ncbi.nlm.nih.gov/pubmed/22018102 http://dx.doi.org/10.1186/1471-2261-11-64

Ejemplares similares

Unexpected Favourable Course of Coronavirus Disease 2019 in Chronic Thromboembolic Pulmonary Hypertension Patients
por: Segura de la Cal, Teresa, et al.
Publicado: (2020)

Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope
por: Linder, Alexandra N., et al.
Publicado: (2022)

Prognostic value of longitudinal vasoreactivity in pediatric pulmonary hypertension
por: Evers, Patrick D., et al.
Publicado: (2022)

Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension
por: Nuche, Jorge, et al.
Publicado: (2020)

Pulmonary vasoreactivity in spontaneously hypertensive rats - Effects of endothelin-1 and leptin
por: Gomart, Samantha, et al.
Publicado: (2014)

Clinical course of COVID-19 in pulmonary arterial hypertension patients
por: Nuche, Jorge, et al.
Publicado: (2020)

Feasibility of a Noninvasive Operability Assessment in Chronic Thromboembolic Pulmonary Hypertension under Real-World Practice
por: Rodriguez Chaverri, Adriana, et al.
Publicado: (2020)

Pulmonary Vascular Capacitance as a Predictor of Vasoreactivity in Idiopathic Pulmonary Arterial Hypertension Tested by Adenosine
por: Shafie, Davood, et al.
Publicado: (2015)

COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
por: Segura de la Cal, Teresa, et al.
Publicado: (2021)

Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Xu, Qi-Xia, et al.
Publicado: (2017)

Clinical Characteristics and Survival of Korean Idiopathic Pulmonary Arterial Hypertension Patients Based on Vasoreactivity
por: Ahn, Jee Hwan, et al.
Publicado: (2014)

Vasoreactive Pulmonary Arterial Hypertension Manifesting With Misleading Epileptic Seizure: Diagnostic and Treatment Pitfalls
por: Farhat, Nesrine, et al.
Publicado: (2019)

Cholesterol: A Novel Regulator of Vasoreactivity in Pulmonary Arteries
por: Grimmer, Benjamin, et al.
Publicado: (2020)

Effectiveness and Safety of Balloon Pulmonary Angioplasty for the Treatment of Patients with Persistent Pulmonary Hypertension after Pulmonary Endarterectomy
por: Maneiro Melon, Nicolas M., et al.
Publicado: (2023)

Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertension
por: Malhotra, Rajeev, et al.
Publicado: (2011)

Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection
por: Zamanian, Roham T., et al.
Publicado: (2020)

Carotid artery vasoreactivity correlates with abdominal aortic vasoreactivity in young healthy individuals but not in patients with abdominal aortic aneurysm
por: Vermeulen, Jenske J.M., et al.
Publicado: (2022)

Acute vasoreactivity test results in severe pulmonary hypertension patients with chronic obstructive pulmonary disease: our experience with 29 cases
por: Asker, Selvi, et al.
Publicado: (2015)

Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension
por: Iglarz, Marc, et al.
Publicado: (2015)

Sex Differences in Chronic Thromboembolic Pulmonary Hypertension. Treatment Options over Time in a National Referral Center
por: Cruz-Utrilla, Alejandro, et al.
Publicado: (2021)

Giant pulmonary aneurysm
por: Hou, Jianglong, et al.
Publicado: (2020)

Lung and heart-lung transplantation in pulmonary arterial hypertension
por: López-Meseguer, Manuel, et al.
Publicado: (2017)

Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response
por: Sun, Yuanyuan, et al.
Publicado: (2020)

Giant pulmonary artery aneurysm in a patient with schistosomiasis-associated pulmonary arterial hypertension
por: Gavilanes, Francisca, et al.
Publicado: (2018)

Complex transposition of the great arteries with pulmonary arterial hypertension and giant pulmonary artery aneurysm
por: Leong, Kai’En, et al.
Publicado: (2018)

Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study
por: Frantz, Robert P., et al.
Publicado: (2023)

Correction: Lung and heart-lung transplantation in pulmonary arterial hypertension
por: López-Meseguer, Manuel, et al.
Publicado: (2018)

Giant pulmonary artery aneurysm
por: Weng, Guo Qin, et al.
Publicado: (2019)

A giant pulmonary artery aneurysm in a patient with severe idiopathic pulmonary arterial hypertension
por: Sonaglioni, Andrea, et al.
Publicado: (2022)

Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling
por: Dumas de la Roque, Eric, et al.
Publicado: (2017)

Heart-lung transplantation for idiopathic pulmonary arterial hypertension and giant pulmonary artery aneurysm – case report
por: Eadington, T., et al.
Publicado: (2020)

Age-, Gender-, and in Vivo Different Doses of Isoproterenol Modify in Vitro Aortic Vasoreactivity and Circulating VCAM-1
por: Nieto-Lima, Betzabé, et al.
Publicado: (2018)

Impact of hypertension severity on arterial stiffness, cerebral vasoreactivity, and cognitive performance
por: Muela, Henrique Cotchi Simbo, et al.
Publicado: (2017)

Interactions among Vascular-Tone Modulators Contribute to High Altitude Pulmonary Edema and Augmented Vasoreactivity in Highlanders
por: Ali, Zahara, et al.
Publicado: (2012)

Conducted Vasoreactivity: the Dynamical Point of View
por: Postnov, D. E., et al.
Publicado: (2015)

Pulmonary artery atresia with ventricular septal defect, segmental pulmonary hypertension, major aortopulmonary collaterals (MAPCAs) and giant MAPCA aneurysm
por: Grabka, Marek, et al.
Publicado: (2016)

Two giants: Giant cell arteritis causing a giant pulmonary artery aneurysm
por: Stevens, Monica, et al.
Publicado: (2023)

Giant Pulmonary Artery Thrombotic Material, Due to Chronic Thromboembolic Pulmonary Hypertension, Mimics Pulmonary Artery Sarcoma
por: Triantafyllidi, Helen, et al.
Publicado: (2021)

Potential Molecular Pathways Related to Pulmonary Artery Aneurysm Development: Lessons to Learn from the Aorta
por: Nuche, Jorge, et al.
Publicado: (2020)

Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study
por: Escribano-Subias, Pilar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sleuv5lp030mk3jne5trfrtfdh